L-THREO-1-PHENYL-2-HEXADECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCL
L-THREO-1-PHENYL-2-HEXADECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCL Basic information
- Product Name:
- L-THREO-1-PHENYL-2-HEXADECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCL
- Synonyms:
-
- L-THREO-1-PHENYL-2-HEXADECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCL
- L-THREO-PPMP
- Hexadecanamide, N-[(1S,2S)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-
- L-threo-PPMP, Glucosylceramide synthase inhibitor
- CAS:
- 207278-87-3
- MF:
- C29H50N2O3
- MW:
- 474.72
- Mol File:
- 207278-87-3.mol
More
Less
L-THREO-1-PHENYL-2-HEXADECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCL Chemical Properties
- Boiling point:
- 642.8±55.0 °C(Predicted)
- Density
- 1.005±0.06 g/cm3(Predicted)
- pka
- 13.60±0.20(Predicted)
More
Less
L-THREO-1-PHENYL-2-HEXADECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCL Usage And Synthesis
Uses
L-threo-PPMP is a GlcT (UDP-Glc: Ceramide β1,1glucosyltransferase) inhibitor. L-threo-PPMP inhibits glycosphingolipid biosynthesis and induces apoptosis. L-threo-PPMP has anti-cancer activity[1].
Definition
ChEBI: (1S,2S)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol is an N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide in which both stereocentres have S configuration. It is an enantiomer of a (1R,2R)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol.
References
[1] Subhash Basu, et al. Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP. Glycoconj J. 2004;20(3):157-68. DOI:10.1023/B:GLYC.0000024254.64450.8b
L-THREO-1-PHENYL-2-HEXADECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCLSupplier
TargetMol Chemicals Inc.
- Tel
- 15002134094
- marketing@targetmol.cn
SHANGHAI ZZBIO CO., LTD.
- Tel
- 15102117276 19921389125
- tech@zzbioco.com
Biosynth Biological Technology (Suzhou) Co Ltd
- Tel
- 51288865780
- sales@biosynth.com
Aladdin Scientific
- Tel
- tp@aladdinsci.com
Guangdong Liusheng Trading Co., Ltd.
- Tel
- 13676271149